 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - VistaGen Therapeutics Inc. (VTGN)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> SPAC List: List of Special Purpose Acquisition Companies |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2019-11-20 Purchase | 2019-11-21 7:52 pm | VistaGen Therapeutics Inc. | VTGN | SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | 15,000 | $0.34 | $5,100 | 15,000 (Indirect Direct) | View |
| 2020-08-21 Purchase | 2020-08-24 4:31 pm | VistaGen Therapeutics Inc. | VTGN | SAXE JON S Director | 30,000 | $0.69 | $20,700 | 50,000 (Indirect Direct) | View |
| 2021-08-17 Purchase | 2021-08-18 6:20 pm | VistaGen Therapeutics Inc. | VTGN | SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | 3,750 | $2.73 | $10,238 | 34,641 (Indirect Direct) | View |
| 2021-09-07 Sale | 2021-09-08 6:58 pm | VistaGen Therapeutics Inc. | VTGN | DOTSON JERROLD DUANE CFO | 30,000 | $3.125 | $93,750 | 72,786 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2019-10-21 Option Award | 2019-10-22 5:02 pm | N/A 2029-10-21 | VistaGen Therapeutics Inc. | VTGN | DOTSON JERROLD DUANE CFO | 150,000 | $0 | 150,000 (Direct) | View |
| 2020-04-23 Option Award | 2020-04-27 5:10 pm | N/A 2030-04-23 | VistaGen Therapeutics Inc. | VTGN | SAXE JON S Director | 75,000 | $0 | 75,000 (Direct) | View |
| 2020-04-23 Option Award | 2020-04-27 5:10 pm | N/A 2030-04-23 | VistaGen Therapeutics Inc. | VTGN | GIN JERRY B Director | 75,000 | $0 | 75,000 (Direct) | View |
| 2020-04-23 Option Award | 2020-04-27 5:10 pm | N/A 2030-04-23 | VistaGen Therapeutics Inc. | VTGN | Underdown Brian J. Director | 75,000 | $0 | 75,000 (Direct) | View |
| 2020-04-23 Option Award | 2020-04-27 5:10 pm | N/A 2030-04-23 | VistaGen Therapeutics Inc. | VTGN | Cunningham Ann Michelle Director | 75,000 | $0 | 75,000 (Direct) | View |
| 2020-04-23 Option Award | 2020-04-27 5:10 pm | N/A 2030-04-23 | VistaGen Therapeutics Inc. | VTGN | Singh Shawn CEO | 300,000 | $0 | 300,000 (Direct) | View |
| 2020-04-23 Option Award | 2020-04-27 5:10 pm | N/A 2030-04-23 | VistaGen Therapeutics Inc. | VTGN | SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | 150,000 | $0 | 150,000 (Direct) | View |
| 2020-04-23 Option Award | 2020-04-27 5:10 pm | N/A 2030-04-23 | VistaGen Therapeutics Inc. | VTGN | Smith Mark Alan CHIEF MEDICAL OFFICER | 150,000 | $0 | 150,000 (Direct) | View |
| 2020-04-23 Option Award | 2020-04-27 5:10 pm | N/A 2030-04-23 | VistaGen Therapeutics Inc. | VTGN | DOTSON JERROLD DUANE CFO | 150,000 | $0 | 150,000 (Direct) | View |
| 2020-04-23 Option Award | 2020-04-27 5:11 pm | N/A 2030-04-23 | VistaGen Therapeutics Inc. | VTGN | MCPARTLAND MARK A. VP | 150,000 | $0 | 150,000 (Direct) | View |
| 2020-06-30 Option Award | 2020-07-01 5:20 pm | N/A N/A | VistaGen Therapeutics Inc. | VTGN | Singh Shawn CEO | 5,000 | $0.448 | 30,375 (Direct) | View |
| 2020-06-30 Option Award | 2020-07-01 5:28 pm | N/A N/A | VistaGen Therapeutics Inc. | VTGN | DOTSON JERROLD DUANE CFO | 5,000 | $0.448 | 5,000 (Direct) | View |
| 2020-06-30 Option Award | 2020-07-01 5:33 pm | N/A N/A | VistaGen Therapeutics Inc. | VTGN | Smith Mark Alan CHIEF MEDICAL OFFICER | 5,000 | $0.448 | 5,000 (Direct) | View |
| 2020-06-30 Option Award | 2020-07-01 5:35 pm | N/A N/A | VistaGen Therapeutics Inc. | VTGN | SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | 5,000 | $0.448 | 67,724 (Direct) | View |
| 2020-12-30 Option Award | 2021-01-04 4:47 pm | N/A 2030-12-30 | VistaGen Therapeutics Inc. | VTGN | GIN JERRY B Director | 75,000 | $0 | 75,000 (Direct) | View |
| 2020-12-30 Option Award | 2021-01-04 4:48 pm | N/A N/A | VistaGen Therapeutics Inc. | VTGN | SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | 5,000 | $0.4521 | 87,724 (Direct) | View |
| 2020-12-30 Option Award | 2021-01-04 4:48 pm | N/A 2030-12-30 | VistaGen Therapeutics Inc. | VTGN | SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | 150,000 | $0 | 150,000 (Direct) | View |
| 2020-12-30 Option Award | 2021-01-04 4:51 pm | N/A 2030-12-30 | VistaGen Therapeutics Inc. | VTGN | MCPARTLAND MARK A. VP | 150,000 | $0 | 150,000 (Direct) | View |
| 2020-12-30 Option Award | 2021-01-04 4:52 pm | N/A 2030-12-30 | VistaGen Therapeutics Inc. | VTGN | Underdown Brian J. Director | 75,000 | $0 | 75,000 (Direct) | View |
| 2020-12-30 Option Award | 2021-01-04 4:54 pm | N/A 2030-12-30 | VistaGen Therapeutics Inc. | VTGN | SAXE JON S Director | 75,000 | $0 | 75,000 (Direct) | View |
| 2020-12-30 Option Award | 2021-01-04 4:55 pm | N/A N/A | VistaGen Therapeutics Inc. | VTGN | Smith Mark Alan CHIEF MEDICAL OFFICER | 5,000 | $0.4521 | 10,000 (Direct) | View |
| 2020-12-30 Option Award | 2021-01-04 4:55 pm | N/A 2030-12-30 | VistaGen Therapeutics Inc. | VTGN | Smith Mark Alan CHIEF MEDICAL OFFICER | 150,000 | $0 | 150,000 (Direct) | View |
| 2020-12-30 Option Award | 2021-01-04 4:57 pm | N/A N/A | VistaGen Therapeutics Inc. | VTGN | DOTSON JERROLD DUANE CFO | 5,000 | $0.4521 | 10,000 (Direct) | View |
| 2020-12-30 Option Award | 2021-01-04 4:57 pm | N/A 2030-12-30 | VistaGen Therapeutics Inc. | VTGN | DOTSON JERROLD DUANE CFO | 150,000 | $0 | 150,000 (Direct) | View |
| 2020-12-30 Option Award | 2021-01-04 4:58 pm | N/A N/A | VistaGen Therapeutics Inc. | VTGN | Singh Shawn CEO | 5,000 | $0.4521 | 35,375 (Direct) | View |
| 2020-12-30 Option Award | 2021-01-04 4:58 pm | N/A 2030-12-30 | VistaGen Therapeutics Inc. | VTGN | Singh Shawn CEO | 300,000 | $0 | 300,000 (Direct) | View |
| 2020-12-30 Option Award | 2021-01-04 4:59 pm | N/A 2030-12-30 | VistaGen Therapeutics Inc. | VTGN | Cunningham Ann Michelle Director | 75,000 | $0 | 75,000 (Direct) | View |
| 2021-02-01 Option Award | 2021-02-02 5:17 pm | N/A 2031-02-01 | VistaGen Therapeutics Inc. | VTGN | Ginski Mark J VP | 200,000 | $0 | 200,000 (Direct) | View |
| 2021-03-19 Exercise | 2021-03-22 7:03 pm | N/A N/A | VistaGen Therapeutics Inc. | VTGN | SAXE JON S Director | 2,500 | $1.5 | 5,751 (Direct) | View |
| 2021-03-19 Exercise | 2021-03-22 7:03 pm | 2018-08-29 2021-04-26 | VistaGen Therapeutics Inc. | VTGN | SAXE JON S Director | 2,500 | $0 | 0 (Direct) | View |
| 2021-03-19 Exercise | 2021-03-22 7:06 pm | N/A N/A | VistaGen Therapeutics Inc. | VTGN | Underdown Brian J. Director | 2,500 | $1.5 | 2,500 (Direct) | View |
| 2021-03-19 Exercise | 2021-03-22 7:06 pm | 2018-08-29 2021-04-26 | VistaGen Therapeutics Inc. | VTGN | Underdown Brian J. Director | 2,500 | $0 | 0 (Direct) | View |
| 2021-04-23 Option Award | 2021-04-27 4:10 pm | N/A 2031-04-23 | VistaGen Therapeutics Inc. | VTGN | Curley Joanne Director | 75,000 | $0 | 75,000 (Direct) | View |
| 2021-04-23 Exercise | 2021-04-27 4:13 pm | N/A N/A | VistaGen Therapeutics Inc. | VTGN | Singh Shawn CEO | 5,000 | $1.5 | 40,375 (Direct) | View |
| 2021-04-23 Exercise | 2021-04-27 4:13 pm | 2018-08-29 2021-04-26 | VistaGen Therapeutics Inc. | VTGN | Singh Shawn CEO | 5,000 | $0 | 0 (Direct) | View |
| 2021-05-01 Option Award | 2021-05-04 4:39 pm | N/A 2031-05-01 | VistaGen Therapeutics Inc. | VTGN | Cunningham Ann Michelle CHIEF COMMERCIAL OFFICER | 300,000 | $0 | 300,000 (Direct) | View |
| 2021-06-30 Option Award | 2021-07-02 4:10 pm | N/A N/A | VistaGen Therapeutics Inc. | VTGN | SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | 3,391 | $1.9465 | 91,115 (Direct) | View |
| 2021-06-30 Option Award | 2021-07-02 4:10 pm | N/A N/A | VistaGen Therapeutics Inc. | VTGN | Singh Shawn CEO | 5,000 | $1.9465 | 45,375 (Direct) | View |
| 2021-06-30 Option Award | 2021-07-02 4:10 pm | N/A N/A | VistaGen Therapeutics Inc. | VTGN | DOTSON JERROLD DUANE CFO | 3,044 | $1.9465 | 13,044 (Direct) | View |
| 2021-06-30 Exercise | 2021-07-02 4:10 pm | N/A N/A | VistaGen Therapeutics Inc. | VTGN | DOTSON JERROLD DUANE CFO | 1,000 | $1.5 | 14,044 (Direct) | View |
| 2021-06-30 Exercise | 2021-07-02 4:10 pm | N/A N/A | VistaGen Therapeutics Inc. | VTGN | DOTSON JERROLD DUANE CFO | 78,918 | $1 | 92,962 (Direct) | View |
| 2021-06-30 Exercise | 2021-07-02 4:10 pm | N/A N/A | VistaGen Therapeutics Inc. | VTGN | DOTSON JERROLD DUANE CFO | 9,824 | $0.398 | 102,786 (Direct) | View |
| 2021-06-30 Exercise | 2021-07-02 4:10 pm | 2018-08-29 2023-10-27 | VistaGen Therapeutics Inc. | VTGN | DOTSON JERROLD DUANE CFO | 1,000 | $0 | 0 (Direct) | View |
| 2021-06-30 Disposition | 2021-07-02 4:10 pm | N/A 2029-05-23 | VistaGen Therapeutics Inc. | VTGN | DOTSON JERROLD DUANE CFO | 36,707 | $0 | 113,293 (Direct) | View |
| 2021-06-30 Exercise | 2021-07-02 4:10 pm | N/A 2029-05-23 | VistaGen Therapeutics Inc. | VTGN | DOTSON JERROLD DUANE CFO | 78,918 | $0 | 34,375 (Direct) | View |
| 2021-06-30 Exercise | 2021-07-02 4:10 pm | N/A 2030-04-23 | VistaGen Therapeutics Inc. | VTGN | DOTSON JERROLD DUANE CFO | 9,824 | $0 | 140,176 (Direct) | View |
| 2021-06-30 Option Award | 2021-07-02 4:11 pm | N/A N/A | VistaGen Therapeutics Inc. | VTGN | Smith Mark Alan CHIEF MEDICAL OFFICER | 2,260 | $1.9465 | 12,260 (Direct) | View |
| 2021-07-06 Option Award | 2021-07-07 4:49 pm | N/A 2031-07-06 | VistaGen Therapeutics Inc. | VTGN | Rotunno Mary L. Director | 75,000 | $0 | 75,000 (Direct) | View |
| 2021-07-21 Option Award | 2021-07-22 4:11 pm | N/A 2031-07-21 | VistaGen Therapeutics Inc. | VTGN | FitzPatrick Margaret M Director | 75,000 | $0 | 75,000 (Direct) | View |
| 2021-08-23 Gift | 2021-09-03 4:19 pm | N/A N/A | VistaGen Therapeutics Inc. | VTGN | SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | 740 | $0 | 33,901 (Indirect) | View |
| 2021-08-23 Gift | 2021-09-03 4:19 pm | N/A N/A | VistaGen Therapeutics Inc. | VTGN | SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | 1,111 | $0 | 61,335 (Direct) | View |